|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Impairment charges related to operating lease right-of-use assets | |||||
| Reorganization costs | |||||
| Litigation costs and related recoveries: | |||||
| Litigation settlement | |||||
| Insurance costs and recoveries, net | |||||
| Litigation costs and related recoveries, net | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Interest expense | |||||
| Non-operating expenses: | |||||
| Loss from change in fair value of redeemable warrants | |||||
| Interest expense | |||||
| Other income, net | |||||
| Income (loss) before income taxes | |||||
| Income taxes | |||||
| Net income (loss) | |||||
| Other comprehensive income: | |||||
| Foreign currency translation gain (loss) | |||||
| Derivative instrument and other adjustments, net of tax | |||||
| Comprehensive income (loss) | |||||
| Net income (loss) attributable to common stockholders | |||||
| Net income (loss) per share attributable to common stockholders: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of shares of Common Stock outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...